Abstract: A method of fabricating a thin-film transistor, the method including: film-forming an active layer, that contains as a main component thereof an oxide semiconductor structured by O and at least two elements among In, Ga and Zn, in a film formation chamber into which at least oxygen is introduced, and b) heat treating the active layer at less than 300° C. in a dry atmosphere, wherein the film-forming a) and the heat treating are carried out such that, given that an oxygen partial pressure with respect to an entire pressure of an atmosphere within the film formation chamber in the film-forming is PO2depo (%), and an oxygen partial pressure with respect to an entire pressure of an atmosphere during the heat treating is PO2anneal (%), the oxygen partial pressure PO2anneal (%) at the time of the heat treating b) satisfies a relationship: ?20/3PO2depo+40/3?PO2anneal??800/43PO2depo+5900/43.

Abstract: A thin film transistor includes at least a gate electrode, a gate insulating film, an active layer, a source electrode and a drain electrode are provided on a substrate, with the source electrode and the drain electrode being provided on the active layer. The active layer is configured of an amorphous oxide semiconductor. A first amount of moisture present in the gate insulating film is smaller than a second amount of moisture present in the active layer.

Abstract: A capsule medication administration system includes: a first capsule for internal body marking; a second capsule for medication; a marking device which makes a marking within a living body; a drug retention section which retains a drug; a release device which releases the drug; a detection device which detects the marking; a decision device which decides whether or not a marking which has been detected by the detection device is a specified marking; and a release control device which operates the release device, if it has been decided by the decision device that it is the specified marking; wherein the first capsule comprises the marking device. The second capsule comprises the drug retention section and the release device.

Abstract: A capsule medication administration system includes: a first capsule for internal body marking; a second capsule for medication; a marking device which makes a marking within a living body; a drug retention section which retains a drug; a release device which releases the drug; a detection device which detects the marking; a decision device which decides whether or not a marking which has been detected by the detection device is a specified marking; and a release control device which operates the release devices if it has been decided by the decision device that it is the specified marking; wherein the first capsule comprises the marking device. The second capsule comprises the drug retention section and the release device.

Abstract: A capsule medication administration system includes: a first capsule for internal body marking; a second capsule for medication; a marking device which makes a marking within a living body; a drug retention section which retains a drug; a release device which releases the drug; a detection device which detects the marking; a decision device which decides whether or not a marking which has been detected by the detection device is a specified marking; and a release control device which operates the release device, if it has been decided by the decision device that it is the specified marking; wherein the first capsule comprises the marking device. The second capsule comprises the drug retention section and the release device.

Abstract: A thin-film transistor including an oxide semiconductor layer is disclosed. The oxide semiconductor layer includes a first area, a second area and a third area forming a well-type potential in the film-thickness direction. The first area forms a well of the well-type potential and has a first electron affinity. The second area is disposed nearer to the gate electrode than the first area and has a second electron affinity smaller than the first electron affinity. The third area is disposed farther from the gate electrode than the first area and has a third electron affinity smaller than the first electron affinity. At least an oxygen concentration at the third area is lower than an oxygen concentration at the first area.

Abstract: An Eu-containing inorganic compound has a polycrystal structure, in which Eu has been doped into a matrix garnet type compound and has formed a solid solution in the matrix garnet type compound. A doping concentration of Eu occupying at an eight-coordination site of the garnet structure falls within the range of more than 0.5 mol % to 50.0 mol %, inclusive. The doping concentration of Eu occupying at the eight-coordination site of the garnet structure should preferably fall within the range of 5.0 mol % to 30.0 mol %.

Abstract: A Pr-doped inorganic compound contains a solid solution having been formed by substitution of at least a part of at least one kind of substitutable ions, which are contained at a substitutable ion site in a matrix oxide, by Pr. The Pr-doped inorganic compound satisfies the condition represented by the formula: 0.91r2?r1?1.05r2 wherein r1 represents the mean ionic radius of ionic radiuses of all of elements, including Pr, which elements constitute the substitutable ion site having been doped with Pr, and r2 represents the ionic radius of Pr.

Abstract: A method of manufacturing a perovskite-type oxide single crystal having a desired composition and exhibiting excellent properties. The method includes the steps of: (a) forming a precursor of a perovskite-type oxide, at least a part of which is in an amorphous state, on a seed single crystal substrate to prepare a complex of the seed single crystal and the precursor, and (b) heat-treating the complex to induce solid phase epitaxy in the precursor, and thereby, forming a single crystal of the perovskite-type oxide.

Abstract: A method of manufacturing a microstructure of perovskite-type oxide single crystal having a desired composition and exhibiting excellent properties. The method includes the steps of: (a) forming a coating layer on a surface of a seed single crystal substrate, the coating layer containing the same metallic elements as those in a predetermined perovskite-type oxide; (b) forming a joint body having a micro-structured precursor of the predetermined perovskite-type oxide adhered to a surface of the coating layer; and (c) heat-treating the joint body to induce solid phase epitaxy, and thereby, single-crystallizing the precursor.

Abstract: An input device capable of easily achieving a high performance is provided. The input device includes an input unit in which an input detecting unit of an electrostatic sensor is disposed on an input portion and an illumination unit in which an illumination portion is disposed on a rear surface of the input portion of the input unit. The input detecting unit of the electrostatic sensor is formed such that it can perform instruction display by illuminating light from the illumination unit.

Abstract: A capsule medication administration system includes: a first capsule for internal body marking; a second capsule for medication; a marking device which makes a marking within a living body; a drug retention section which retains a drug; a release device which releases the drug; a detection device which detects the marking; a decision device which decides whether or not a marking which has been detected by the detection device is a specified marking; and a release control device which operates the release devices if it has been decided by the decision device that it is the specified marking; wherein the first capsule comprises the marking device. The second capsule comprises the drug retention section and the release device.

Abstract: A capsule medication administration system includes: a first capsule for internal body marking; a second capsule for medication; a marking device which makes a marking within a living body; a drug retention section which retains a drug; a release device which releases the drug; a detection device which detects the marking; a decision device which decides whether or not a marking which has been detected by the detection device is a specified marking; and a release control device which operates the release devices if it has been decided by the decision device that it is the specified marking; wherein the first capsule comprises the marking device. The second capsule comprises the drug retention section and the release device.

Abstract: A capsule medication administration system includes: a first capsule for internal body marking; a second capsule for medication; a marking device which makes a marking within a living body; a drug retention section which retains a drug; a release device which releases the drug; a detection device which detects the marking; a decision device which decides whether or not a marking which has been detected by the detection device is a specified marking; and a release control device which operates the release device, if it has been decided by the decision device that it is the specified marking; wherein the first capsule comprises the marking device. The second capsule comprises the drug retention section and the release device.

Abstract: A Tb-doped luminescent compound contains Tb and at least two kinds of metal elements other than Tb, and emits light by irradiation with excitation light. In the Tb-doped luminescent compound, the concentration of Tb with respect to the total number of moles of all of the metal elements including Tb is within the range of more than 3.75 mol % to 20.625 mol % inclusive.

Abstract: A coordinate input device includes a housing containing a movable member, a resilient member formed of a coil spring, and first and second detectors for detecting the sliding direction and the sliding distance of the movable member. The movable member in an initial position before a sliding operation faces a supporter of a first cover provided in the housing. When the movable member is slid in a certain direction, the resilient member is stretched in the certain direction and the first and second detectors detect the sliding direction and the sliding distance of the movable member. When the sliding operation of the movable member is finished, a resilient force of the resilient member stretched in the certain direction forces the movable member to return automatically to the initial position.

Abstract: A switch device is provided that includes a first switch portion in which an upper electrode and lower electrodes face each other at a predetermined gap and a second switch portion having metal domes which are disposed at a lower side facing the first switch portion and expand to a predetermined height. A first spacer having a predetermined thickness A is disposed in the first switch portion to form a gap between the upper electrode and the lower electrodes, a second spacer having a thickness B equal to or greater than the expanded height of the metal domes is disposed in the second switch portion, and the thickness of the second spacer is greater than that of the first spacer.

Abstract: A Pr-doped inorganic compound contains a solid solution having been formed by substitution of at least a part of at least one kind of substitutable ions, which are contained at a substitutable ion site in a matrix oxide, by Pr. The Pr-doped inorganic compound satisfies the condition represented by the formula: 0.91r2?r1?1.05r2 wherein r1 represents the mean ionic radius of ionic radiuses of all of elements, including Pr, which elements constitute the substitutable ion site having been doped with Pr, and r2 represents the ionic radius of Pr.

Abstract: A garnet type compound has a composition, which may be represented by the general formula: A1(III)3-2xA2(II)xA3(III)xB(III)2C1(III)3-xC2(IV)xO12 wherein each of the Roman numerals in the parentheses represents the valence number of ion; each of A1, A2, and A3 represents the element at the A site; B represents the element at the B site; each of C1 and C2 represents the element at the C site; each of A1, A2, B, C1, and C2 represents at least one kind of element exhibiting the corresponding valence number of ion defined above; A3 represents at least one kind of element selected from the group consisting of trivalent rare earth elements of La, Ce, Pr, Nd, Sm, Eu, Gd, Tb, Dy, Ho, Er, Tm, Yb, and Lu; A1 and A3 represent different elements; x represents a number satisfying a condition 0<x<1.5, provided that cases where x=1.0 are excluded; and O represents the oxygen atom.

Abstract: A multistep switch includes a first input device, a second input device, and a third input device. The first input device is a capacitive type sensor. The second input device is disposed behind the first input device and capable of switching by pressure when the first input device is depressed. The third input device is disposed behind the second input device and capable of switching by pressure when the first input device is depressed and the second input device is depressed.